share_log

Nyxoah Completes $50M Offering And Subsequent Sale Of Additional Shares, Raising $52.5M

Nyxoah Completes $50M Offering And Subsequent Sale Of Additional Shares, Raising $52.5M

Nyxoah完成了5000萬美元的發行和隨後額外股票的出售,籌集了5,250萬美元
Benzinga ·  05/31 03:15

Nyxoah intends to use the net proceeds from the proposed offering (i) for pre-commercialization and commercialization activities in the United States; (ii) to continue gathering clinical data and to support physician initiated clinical research projects related to OSA patient treatments; (iii) to further finance research and development activities related to the next generation of the Genio system and to continue to build a pipeline of new technologies and explore potential collaboration opportunities in the field of monitoring and diagnostics for OSA; and (iv) for other general corporate purposes, including, but not limited to, working capital, capital expenditures, investments, acquisitions, should the Company choose to pursue any, and collaborations.

Nyxoah打算利用擬議中的發行所得款項(i)用於在美國進行商業化前和商業化活動;(ii)繼續收集臨床數據並支持與OSA患者治療相關的醫生主導的臨床研究項目;(iii)進一步融資下一代Genio系統的研究和開發活動,並繼續建立一系列新技術和探索OSA監測和診斷領域的潛在合作機會;以及(iv)用於其他一般企業目的,包括但不限於營運資金、固定資產支出、投資、收購(如果公司決定追求任何),以及合作。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論